Rebecca R. Ammons

Next Post

Microbiome research points way to tackling food allergies and more

Thu Jul 28 , 2022
French biotech Enterome has signed a strategic R&D collaboration and license settlement with Switzerland’s Nestlé Health Science. Component of a new wave of businesses intrigued in the microbiome, Enterome has been doing the job on its Mimicry drug discovery system, leveraging interactions between the intestine microbiome and the immune method.  […]

You May Like